Literature DB >> 9788593

Induction of apoptosis by deregulated expression of DNA topoisomerase IIalpha.

J P McPherson1, G J Goldenberg.   

Abstract

DNA topoisomerase II (topo II) is an essential nuclear enzyme required for chromatin condensation and chromosome segregation during mitosis. Forced overexpression of topo IIalpha was found to cause morphological changes in recipient cells associated with apoptosis. This induction of apoptosis required nuclear localization of topo IIalpha, yet was independent of the DNA cleavage-religation activity of the enzyme. Apoptosis mediated by topo IIalpha deregulation was blocked by overexpression of crmA, a specific inhibitor of certain caspases, but not by bcl-2. topo IIalpha-induced apoptosis was also blocked by overexpression of a dominant-acting mutant of stress-activated protein kinase kinase (SEK1/MKK4) but not by the overexpression of its normal counterpart. Furthermore, apoptosis was blocked by coexpression of a dominant-negative form of the cyclin-dependent kinase cdk2 but not by dominant-negative cdc2. These results provide a rationale for the tight regulation of topo IIalpha levels through the cell cycle in that deregulation of topo IIalpha expression results in apoptotic cell death.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9788593

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  Protein kinase C delta activates topoisomerase IIalpha to induce apoptotic cell death in response to DNA damage.

Authors:  Kiyotsugu Yoshida; Tomoko Yamaguchi; Hirokuni Shinagawa; Naoe Taira; Keiichi I Nakayama; Yoshio Miki
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

Review 2.  DNA topoisomerase II and its growing repertoire of biological functions.

Authors:  John L Nitiss
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

Review 3.  Topoisomerase 2 alpha: a real predictor of anthracycline efficacy?

Authors:  Atocha Romero; Trinidad Caldés; Eduardo Díaz-Rubio; Miguel Martín
Journal:  Clin Transl Oncol       Date:  2012-03       Impact factor: 3.405

4.  Predictive value of topoisomerase II alpha immunostaining in urothelial bladder carcinoma.

Authors:  L Nakopoulou; A Zervas; A C Lazaris; C Constantinides; C Stravodimos; P Davaris; C Dimopoulos
Journal:  J Clin Pathol       Date:  2001-04       Impact factor: 3.411

5.  Anticancer activity and possible mode of action of 4-O-podophyllotoxinyl 12-hydroxyl-octadec-Z-9-enoate.

Authors:  Guoyi Ma; Shabana I Khan; Jamal Mustafa; Larry A Walker; Ikhlas A Khan
Journal:  Lipids       Date:  2005-03       Impact factor: 1.880

6.  Phosphorylation and stabilization of topoisomerase IIα protein by p38γ mitogen-activated protein kinase sensitize breast cancer cells to its poisons.

Authors:  Xiaomei Qi; Songwang Hou; Adrienne Lepp; Rongshan Li; Zainab Basir; Zhenkun Lou; Guan Chen
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

7.  The dynamics of DNA topoisomerase IIalpha in living cells.

Authors:  John R Daum; Yin Yuan Mo; Gary J Gorbsky
Journal:  Methods Mol Biol       Date:  2009

8.  Dynamics of human DNA topoisomerases IIalpha and IIbeta in living cells.

Authors:  Morten O Christensen; Morten K Larsen; Hans Ullrich Barthelmes; Robert Hock; Claus L Andersen; Eigil Kjeldsen; Birgitta R Knudsen; Ole Westergaard; Fritz Boege; Christian Mielke
Journal:  J Cell Biol       Date:  2002-04-01       Impact factor: 10.539

9.  DNA-AP sites generation by etoposide in whole blood cells.

Authors:  Emilio Rojas; Patricia Mussali; Efrain Tovar; Mahara Valverde
Journal:  BMC Cancer       Date:  2009-11-16       Impact factor: 4.430

10.  C-terminal regions of topoisomerase IIalpha and IIbeta determine isoform-specific functioning of the enzymes in vivo.

Authors:  René M Linka; Andrew C G Porter; Arsen Volkov; Christian Mielke; Fritz Boege; Morten O Christensen
Journal:  Nucleic Acids Res       Date:  2007-05-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.